Ophthalmic formulations
TW202626029APending Publication Date: 2026-07-01PELTHOS THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114141251
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-21
- Filing Date
- 2025-10-23
- Publication Date
- 2026-07-01
Abstract
The present invention relates to ophthalmic formulations comprising 2-{[3-(5-chloro-2-{2-chloro-5-fluoro-4-[(1,3-thiazol-4-yl)sulfamoyl]phenoxy}phenyl)propyl]amino}acetamide or a pharmaceutically acceptable salt thereof, to methods for preparation thereof, and uses thereof for treatment of various eye conditions (e.g., pain).
Need to check novelty before this filing date? Find Prior Art